Merge Back in the Mix for AMICAS

Following an amended proposal from medical imaging software vendor Merge Healthcare to acquire rival AMICAS Inc., Boston-based AMICAS has concluded that the proposal now is superior to an earlier acquisition offer from investment firm Thoma Bravo, LLC.

Milwaukee-based Merge recently made an unsolicited bid of $6.05 per share, compared with Thoma Bravo's $5.35 bid. AMICAS initially rejected Merge's offer, questioning how solid the financing arrangements were.

Now satisfied with those arrangements, AMICAS will offer to negotiate in good faith with Thoma Bravo during the five business day period ending March 8. Afterward, AMICAS will terminate its agreement with Thoma Bravo if the Merge proposal continues to be superior.

--Joseph Goedert